1. Lou A, Elnenaei M, Liu E, et al. Evaluation of a novel albumin platelet product (APP) fibrosis index and three ...

More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal ...

Incyte ( INCY) on Sunday said the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to ...

Key Takeaways An experimental drug can help many with a rare autoimmune bleeding conditionMore than half of people with ...

ITP is an autoimmune condition where the body’s immune cells mistakenly attack platelets, the blood cells responsible for clotting.

Time is critical for patients this December. The American Red Cross urges donors to make an appointment to give blood or ...

Dengue cases in Tamil Nadu rise, but improved awareness and protocols lead to fewer complications and deaths this year.

A routine Complete Blood Count (CBC) offers vital insights into your health, revealing levels of red blood cells for oxygen transport, white blood cells for immunity, and platelets for clotting.

An experimental monoclonal antibody called ianalumab had promising results for more than half of patients with primary immune thrombocytopenia enrolled in a phase 3 trial, according to data published ...

More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune ...

This article was reviewed by Felix Gussone, MD. How to Read Blood Test Results: What “Normal” Really Means for Your Health ...

He was healthy and fit at 54, an avid runner with no vices — he didn't smoke, drink or do drugs. So when he suddenly ...